Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Advancing Dedicated Breast Imaging at a Market Crossroads
IzoView Breast CT designed as the first breast-dedicated CT imaging system to eliminate tissue overlap and compression limitations specifically for breast cancer screening in patients with dense breast tissue Platform model supports multiple future clinical applications, including diagnosis and treatment planning without hardware replacement Regulatory pathway alignment and commercialization planning position Izotropic for potential market entry into a $8.7B global breast imaging sector Imaging’s Stagnation Meets a New Wave of Purpose-Built Devices For decades, breast cancer screening has relied heavily on mammography, a compression-based modality that, while valuable, carries persistent shortcomings. Dense breast tissue, which affects nearly half of women,…
